index - Équipe Biomarqueurs Radiopharmaceutiques et Neurochimiques

Derniers dépôts

Chargement de la page

Documents en texte intégral

66

Notices

64

 

Mots clés

5-HT1A Autoradiography Alpha-synuclein 18F-florbetapir Drug discovery Multiple system atrophy Power law exponent Olfaction 5-Ht1A and 5-HT6 receptors Biased agonism 18FFluorodeoxyglucose Cerebrospinal fluid Autoimmune encephalitis Central nervous system Noradrenaline Radiotracer Amyloid-beta 14-3-3 protein Neuroinflammation Amyloid-β plaques Remote memory Acute ischemic stroke Atomoxetine 18FFDG micro PET Biomarkers Inflammation Biomarqueurs Recent memory Anxiety behavior 3D virtual histopathology Non-human primate Middle cerebral artery occlusion Amyloid‐β 18 FF13640 Alzheimer diagnosis Stroke Binding Synucleinopathies Alzheimer's disease Serotonin Aβ40 System-level consolidation Biomarkers neuroinflammation positron emission tomography Alzheimer 5-HT6 receptor Alert system Α2-adrenergic receptors Magnetic resonance imaging Multiple sclerosis Analytical confounders Attention-deficit hyperactivity disorder Amyotrophic lateral sclerosis Neuropharmacology Agonist 5-HT 1A receptors Striatum PET imaging PET/MRI Anti-CD20 Proteinopathies Automation 11CPF-3274167 Dementia Frontotemporal lobar degeneration 5-HT1A receptors Alzheimer’s disease 5-HT 6 receptor Aβ42 Agonists Animal models BIOMARKAPD Sniffing Piriform cortex PET Blood biomarker Agonistes 18FFDG Bayesian inference Creutzfeldt-Jakob disease Accident vasculaire cérébral TEP A-BETA Positron emission tomography Atmospheric pollution 11Cyohimbine Neuroimaging Adverse events Magnetic resonance elastography Amyloid Fibril aggregates Biomarker MicroPET Pharmaco-fUS Amyloid-beta peptides Animal model Neurodegenerative diseases Parkinson's disease Locus coeruleus Brain